Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL681049 | 1.00 | CA4 (0.55) | — | |
| Bicarbonate SCHEMBL9777799 | 1.00 | CA4 (0.55) | — | |
| Bicarbonate SCHEMBL890048 | 0.95 | — | — | |
| Bicarbonate SCHEMBL14562574 | 0.95 | — | — | |
| Bicarbonate SCHEMBL950160 | 0.94 | — | — | |
| Bicarbonate SCHEMBL154738 | 0.94 | CA4 (0.60) | — | |
| Bicarbonate SCHEMBL2402027 | 0.94 | — | — | |
| Bicarbonate SCHEMBL14562576 | 0.91 | CA4 (0.46) | — | |
| Bicarbonate SCHEMBL3686141 | 0.89 | — | — | |
| Bicarbonate SCHEMBL8712057 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115697698-A | Laminate and method for using laminate | 积水化学工业株式会社 | 2023-02-03 | — | — | CN | disclosed |
| CN-114341226-A | Polyol-containing composition, foamable polyurethane composition and polyurethane foam | 积水化学工业株式会社 | 2022-04-12 | — | — | CN | disclosed |
| EP-1341528-B1 | RAPIDLY DISINTEGRATING TABLET COMPRISING AN ACID-LABILE ACTIVE INGREDIENT | NYCOMED GMBH (DE) | 2012-01-18 | — | — | EP | disclosed |
| US-8007760-B2 | Process for producing enhanced alumina | UOP LLC (US) | 2011-08-30 | — | — | US | disclosed |
| EP-2358636-A1 | PROCESS FOR PRODUCING ENHANCED ALUMINA | UOP LLC (US) | 2011-08-24 | — | — | EP | disclosed |
| EP-2356074-A1 | PROCESS FOR CONVERSION OF ALUMINUM OXIDE HYDROXIDE | UOP LLC (US) | 2011-08-17 | — | — | EP | disclosed |
| US-7947250-B2 | Process for conversion of aluminum oxide hydroxide | UOP LLC (US) | 2011-05-24 | — | — | US | disclosed |
| WO-2010068321-A1 | PROCESS FOR PRODUCING ENHANCED ALUMINA | UOP LLC (US) | 2010-06-17 | — | — | WO | disclosed |
| US-20100148116-A1 | Process for Conversion of Aluminum Oxide Hydroxide | UOP LLC | 2010-06-17 | — | — | US | disclosed |
| US-20100150820-A1 | Process for Producing Enhanced Alumina | UOP LLC | 2010-06-17 | — | — | US | disclosed |
| EP-1341528-A1 | RAPIDLY DISINTEGRATING TABLET COMPRISING AN ACID-LABILE ACTIVE INGREDIENT | ALTANA Pharma AG (DE) | 2003-09-10 | — | — | EP | disclosed |
| EP-0864579-B1 | Bismuth salts of moenomycin-like antibiotics, preparation, use and pharmaceuticals containing such salts | HOECHST AG (DE) | 2003-06-04 | — | — | EP | disclosed |
| WO-2002045694-A1 | RAPIDLY DISINTEGRATING TABLET COMPRISING AN ACID-LABILE ACTIVE INGREDIENT | ALTANA PHARMA AG (DE) | 2002-06-13 | — | — | WO | disclosed |
| US-6242424-B1 | TREATMENT OF GASTRIC ULCERS AND FOR THE CONTROL OF HELICOBACTER PYLORI. | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2001-06-05 | — | — | US | disclosed |
| EP-0655249-B1 | Moenomycin as a medicament for the treatment of stomach ulcer | HOECHST AG (DE) | 2001-03-07 | — | — | EP | disclosed |
| US-6077830-A | COMPRISING BISMUTH SALTS OF ANTIBIOTIC OF MOENOMYCIN GROUP; FOR TREATING GASTRITIS, UCLERS, CONTROLLING HELICOBACTER PYLORI, STOMACH CANCER | HOECHST AKTIENGESELLSCHAFT (DE) | 2000-06-20 | — | — | US | disclosed |
| EP-0864579-A2 | Bismuth salts of moenomycin-like antibiotics, preparation, use and pharmaceuticals containing such salts | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-09-16 | — | — | EP | disclosed |
| EP-0655249-A1 | Moenomycin as a medicament for the treatment of stomach ulcer | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-05-31 | — | — | EP | disclosed |
| EP-0241804-B1 | PRESERVED ANTACID PREPARATIONS | BAYER AG (DE) | 1992-01-15 | — | — | EP | disclosed |
| EP-0241804-A2 | Preserved antacid preparations | BAYER AG (DE) | 1987-10-21 | — | — | EP | disclosed |